john_bell

Immunocore appoints key scientist to board

pharmafile | March 31, 2015 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing |  immunocore, john bell 

UK biotech Immunocore has appointed the Regius Professor of medicine at Oxford University and chairman of the office for the strategic co-ordination of health research Sir John Bell to its board.

A distinguished scientist in the fields of genomic and genetic research and immunology, Sir John takes significant experience in healthcare business to the Oxford firm, having been a founding director at three biotech companies: Avidex (a precursor to Immunocore which was acquired by MediGene in 2006) Oxagen and PowderJect Pharmaceuticals (acquired by Chiron Corporation in 2003).

He currently also serves on the boards of Roche and Genentech and had a previous role on the scientific advisory board at AstraZeneca. Sir John was involved in the founding of the Wellcome Trust Centre for Human Genetics at Oxford University, now chairs the scientific committee of UK Biobank and the Global Health Scientific Advisory Board of the Bill and Melinda Gates Foundation, and is one of two life science champions for the UK – reporting to the UK prime minister.

Advertisement

“Professor Sir John Bell’s scientific expertise and industry experience are second to none, and his appointment will be a huge asset to Immunocore as it advances its immuno-oncology platform technology for the treatment of diseases with high unmet medical need including cancer, viral infections and autoimmune diseases,” says Dr Eliot Forster, chief executive of Immunocore.

Related Content

astrazeneca_plaque

AstraZeneca loses two senior executives as biotechs appoint new CEOs

Two of AstraZeneca’s senior executives have been poached by the biotech firms Ironwood Pharmaceuticals and …

nicolas_raymond

The measurement underpinning government goals for UK life sciences

Michael Adeogun, Head of Life Sciences and Health at National Physical Laboratory, discusses the importance …

Life sciences minister George Freeman

Government launches Accelerated Access Review call to action

The Government is urging pharma companies to participate in the Accelerated Access Review, and will …

The Gateway to Local Adoption Series

Latest content